Study Stopped
The study was terminated prematurely after 2 years because during to the COVID-19 pandemic, the face-to-face mode of administration of the interviews in the General Adult Population Sample was not feasible.
Cross-Sectional Survey on the Use of Tobacco Products - Germany
1 other identifier
observational
6,284
1 country
1
Brief Summary
The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Germany.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2018
CompletedFirst Submitted
Initial submission to the registry
May 4, 2018
CompletedFirst Posted
Study publicly available on registry
May 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 24, 2020
CompletedFebruary 28, 2024
February 1, 2024
2 years
May 4, 2018
February 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Prevalence of current tobacco use
Prevalence of current tobacco use status in the study population.
Study duration (3 years).
Past tobacco use status
Past tobacco use status (cigarette, IQOS and other innovative products) in the study population.
Study duration (3 years).
Self-reported health status
Association between self-reported health status and use of tobacco products in the study population.
Study duration (3 years).
Perceived risk
Association between patterns of use with perceived risk.
Study duration (3 years).
IQOS use experience
Describe the IQOS user experience, including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits).
Study duration (3 years).
Study Arms (2)
General Population
Adults living in Germany.
IQOS Users
Adult current IQOS users (at the time of survey) living in Germany who are registered in the Germany IQOS User Database and agreed to be contacted for research purposes at the time of registration.
Interventions
Face-to-face survey to estimate the prevalence of current tobacco use status in the general population of Germany.
Online survey to describe patterns of use in adult IQOS users residing in Germany.
Eligibility Criteria
The study population will be limited to residents of Germany.
You may qualify if:
- Legally permitted to buy tobacco products in Germany (≥18 years of age).
- Currently residing in Germany.
- Able to read, write and understand German.
- Consent to participate in the survey
- Has used more than 100 HEETS tobacco sticks in his or her lifetime.
- Is currently using IQOS.
- Has access to the internet.
- Is not currently employed by Philip Morris International or any of its affiliates
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Philip Morris Products S.A.
Lausanne, Canton of Vaud, 1007, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Pierpaolo Magnani
Philip Morris Products S.A.
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2018
First Posted
May 16, 2018
Study Start
March 12, 2018
Primary Completion
February 24, 2020
Study Completion
February 24, 2020
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share